Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 13/20 | 0.62 |
| ▸ | DDB1 | Q16531 | 12/20 | 0.62 |
| ▸ | MAP1LC3B | Q9GZQ8 | 3/20 | 0.52 |
| ▸ | STAT3 | P40763 | 1/20 | 0.50 |
| ▸ | AR | P10275 | 1/20 | 0.49 |
| ▸ | IKZF3 | Q9UKT9 | 3/20 | 0.49 |
| ▸ | GSK3B | P49841 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23705631 | 1.00 | CRBN (0.62) | CRBNDDB1MAP1LC3BSTAT3AR | |
| SCHEMBL22150447 | 0.86 | CRBN (0.76) | CRBNDDB1MAP1LC3BSTAT3AR | |
| SCHEMBL23133984 | 0.86 | CRBN (0.76) | CRBNDDB1MAP1LC3BSTAT3AR | |
| SCHEMBL23124803 | 0.86 | CRBN (0.76) | CRBNDDB1MAP1LC3BSTAT3AR | |
| SCHEMBL22276487 | 0.85 | CRBN (0.75) | CRBNDDB1MAP1LC3BSTAT3AR | |
| SCHEMBL20294800 | 0.85 | CRBN (0.75) | CRBNDDB1MAP1LC3BSTAT3IKZF3 | |
| SCHEMBL20294798 | 0.85 | CRBN (0.75) | CRBNDDB1MAP1LC3BSTAT3IKZF3 | |
| SCHEMBL30830842 | 0.84 | CRBN (0.68) | CRBNDDB1MAP1LC3BSTAT3AR | |
| SCHEMBL27314606 | 0.82 | CRBN (0.64) | CRBNDDB1MAP1LC3BSTAT3AR | |
| SCHEMBL22500886 | 0.82 | CRBN (0.75) | CRBNDDB1MAP1LC3BSTAT3AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115335373-B | Compounds and uses thereof | 福宏治疗公司 | 2025-05-20 | — | — | CN | disclosed |
| CN-116867785-A | Compounds and uses thereof | 福宏治疗公司 | 2023-10-10 | — | — | CN | disclosed |
| EP-4097096-A2 | COMPOUNDS AND USES THEREOF | Foghorn Therapeutics Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| WO-2022109396-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. (US) | 2022-05-27 | — | — | WO | disclosed |